일신바이오
Financials
Valuation Metrics
일신바이오's Market Cap is ₩403B. At end of 2025 it was ₩712B. Ranked #1874 of 2,436 in KR market (top 77%), #1159 of 1,649 on KOSDAQ (top 70%), #304 of 365 in Capital Goods (top 83%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 40.33B KRW | KR#1,874/2,436 Sec#304/365 |
| Revenue | 15.16B KRW | KR#2,207/2,436 Sec#338/365 |
| Net Income | 5.11B KRW | KR#1,119/2,436 Sec#179/365 |
| Total Assets | 72.69B KRW | KR#1,967/2,436 Sec#317/365 |
| Net Assets | 65.35B KRW | KR#1,690/2,436 Sec#272/365 |
| Employees | 37 | KR#2,130/2,436 Sec#317/365 |
| Value | ||
| P/E | 7.90x | KR#556/2,436 Sec#84/365 |
| P/B | 0.62x | KR#1,026/2,436 Sec#139/365 |
| PEG | 0.17x | KR#480/2,436 Sec#73/365 |
| P/S | 2.66x | KR#1,967/2,436 Sec#289/365 |
| EV/EBITDA | 8.48x | KR#500/2,436 Sec#69/365 |
| FCF Yield | 13.05% | KR#517/2,436 Sec#77/365 |
| Profitability | ||
| ROE | 7.81% | KR#709/2,436 Sec#114/365 |
| ROA | 7.02% | KR#431/2,436 Sec#63/365 |
| Op. Margin | 30.06% | KR#56/2,436 Sec#5/365 |
| Revenue Growth | 33.54% | KR#433/2,436 Sec#76/365 |
| Earnings Growth | 47.20% | KR#584/2,436 Sec#93/365 |
| Financial Health | ||
| Debt Ratio | 111.22% | KR#467/2,436 Sec#46/365 |
| Total Debt | 0 KRW | KR—/2,436 Sec—/365 |
| FCF | 5.26B KRW | KR#889/2,436 Sec#141/365 |
| Cash | 1.66B KRW | KR#2,279/2,436 Sec#344/365 |
| Current Ratio | 8.32x | KR#136/2,436 Sec#11/365 |
| Net Debt/EBITDA | -0.36x | KR#609/2,436 Sec#78/365 |
| Dividend | ||
| Div. Yield | 1.11% | KR#1,104/2,436 Sec#157/365 |
| Div. Growth | 42.86% | KR#265/2,436 Sec#57/365 |
| Performance | ||
| 1Y Return | -46.64% | KR#1,999/2,436 Sec#319/365 |
| 1M Return | -8.62% | KR#1,675/2,436 Sec#208/365 |
| From 52W High | -55.62% | KR#1,480/2,436 Sec#208/365 |
| 1Y MDD | -57.37% | KR#1,269/2,436 Sec#168/365 |
| Trading | ||
| Volume | 72,397 shares | KR#1,125/2,436 Sec#202/365 |
| Foreign Own. | 3.75% | KR#928/2,436 Sec#166/365 |
| Per Share | ||
| EPS | 115 KRW | KR#1,333/2,436 Sec#214/365 |
| BPS | 1,568 KRW | KR#2,146/2,436 Sec#336/365 |
Company Info
Established in 1988 and converted to a corporation in 1994, the company was listed on KOSDAQ in 2007 and changed its name to Ilshinbiobase in 2009. It specializes in bio-equipment, manufacturing, selling, and exporting research equipment like lyophilizers for biotechnology research and ultra-low temperature freezers, alongside large industrial lyophilizers. Leveraging vacuum, refrigeration, and control technologies, the company offers a diverse product lineup and pursues growth by developing high-performance automatic control systems and expanding global GMP-compliant models. Ilshinbio is headquartered in Dongducheon-si, Gyeonggi-do.